AstraZeneca demolishing unused site; Taiwan nails companies for using industrial ingredients

> The Taiwan FDA has suspended two companies for using industrial-grade ingredients in stomach medicines. Story

> The European Medicines Agency plans to work with national regulators to share information about inspections and supply issues to improve efficiencies and reduce the risk of counterfeit drugs making their way into the legit supply chain. Report 

> Blisterpack producer Klöckner Pentaplast Group has opened a facility in the University of Virginia Research Park in Charlottesville, VA. Report

> AstraZeneca ($AZN) has started demolishing a 450,000-square-foot former laboratory space at its North American headquarters campus in Fairfax, VA. Story

> Theravectys has gotten approval from French regulators for its new manufacturing facility where it will produce lentiviral vectors for clinical development and do cell work for chimeric antigen receptors (CARs) and T-cell receptor (TCR)-based cell therapies. Report

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.